Briefing: Community-Wide Opioid Overdose Prevention Program

Research Focus

This program targets the urgent public health crisis of opioid overdose mortality by funding the development and implementation of community-based prevention initiatives centered on expanding access to FDA-approved opioid overdose reversal medications (such as naloxone/Narcan). The funder seeks evidence-based approaches to increase medication availability, uptake, and appropriate use across diverse community settings—including harm reduction programs, emergency departments, primary care, and community pharmacies. Successful projects will generate implementation evidence on scalable models for overdose reversal medication distribution, training, and integration into existing public health infrastructure, with the ultimate goal of reducing preventable opioid-related deaths at the population level.

At a Glance

• Who can apply: Not stated
• Funding & project length: Not stated
• Award / mechanism: Not stated
• Key dates: Not stated
• Best fit for: Public health, implementation science, and addiction medicine researchers with experience in community-based interventions, opioid use disorder prevention, and health systems integration

Note: This FOA lacks critical details on eligibility, budget, timeline, and submission dates. Contact the funder directly before investing application effort.